1. Long-term efficacy and safety of the intramyocardial implantation of autologous bone marrow cells for the treatment of ischemic heart disease 
Tao-Sheng Li, MD, PhD, Masanori Murakami, MD, PhD, Toshiro Kobayashi, MD, PhD, Bungo Shirasawa, MD, PhD, Akihito Mikamo, MD, PhD, Kimikazu Hamano, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 134, Issue 5, Pages (November 2007)
DOI: /j.jtcvs
Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Procedure used for the intramyocardial injection of bone marrow mononuclear cells. A, Image of the target zone of cell injection. B, The volume was 0.1 mL per injection. Injections were spaced about 1 cm apart and given via a 1-mL syringe and a 26-gauge needle.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions